Michael A. Narachi
2010
In 2010, Michael A. Narachi earned a total compensation of $3.1M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $590,625 |
|---|---|
| Option Awards | $1,979,716 |
| Salary | $525,000 |
| Other | $7,626 |
| Total | $3,102,967 |
Narachi received $2M in option awards, accounting for 64% of the total pay in 2010.
Narachi also received $590.6K in bonus, $525K in salary and $7.6K in other compensation.
Rankings
In 2010, Michael A. Narachi's compensation ranked 1,902nd out of 10,439 executives tracked by ExecPay. In other words, Narachi earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,902 out of 10,439 | 82nd |
Division Manufacturing | 663 out of 3,838 | 83rd |
Major group Chemicals And Allied Products | 125 out of 921 | 86th |
Industry group Drugs | 72 out of 680 | 89th |
Industry Pharmaceutical Preparations | 55 out of 481 | 89th |
Source: SEC filing on April 23, 2013.
Narachi's colleagues
We found five more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2010.
2010
Heather Turner
Orexigen Therapeutics
General Counsel
2010
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2010
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2010
Preston Klassen
Orexigen Therapeutics
Head of Global Contrave Program and Senior Vice President, Product Development
2010
Joseph Hagan
Orexigen Therapeutics